Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Corine Ekhart

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
Expert Opinion on Drug Safety|July 18, 2019
Safety profile of non-vitamin K oral anticoagulants (NOACs) from a patient perspective: a web-based cohort event monitoring studyLeàn Rolfes, Corine Ekhart, Judith Hendriks, et al.
Drug Safety|February 28, 2018
Sex Differences in Reported Adverse Drug Reactions of Selective Serotonin Reuptake InhibitorsCorine Ekhart, Florence van Hunsel, Joep Scholl, et al.
Cancer Chemotherapy and Pharmacology|April 24, 2008
Altered cyclophosphamide and thiotepa pharmacokinetics in a patient with moderate renal insufficiencyCorine Ekhart, J Martijn Kerst, Sjoerd Rodenhuis, et al.
Pharmacogenomics|September 1, 2018
Cytochrome P450 genotype and aggressive behavior on selective serotonin reuptake inhibitorsCorine Ekhart, Maja Matic, Agnes Kant, et al.
Pain Practice : the Official Journal of World Institute of Pain|June 28, 2016
Metamizole (Dipyrone) as an Alternative Agent in Postoperative Analgesia in Patients with Contraindications for Nonsteroidal Anti-Inflammatory DrugsJorieke Konijnenbelt-Peters, Charlotte van der Heijden, Corine Ekhart, et al.
Cancer Treatment Reviews|September 6, 2008
An overview of the relations between polymorphisms in drug metabolising enzymes and drug transporters and survival after cancer drug treatmentCorine Ekhart, Sjoerd Rodenhuis, Paul H M Smits, et al.
Pharmacogenetics and Genomics|October 16, 2008
Relations between polymorphisms in drug-metabolising enzymes and toxicity of chemotherapy with cyclophosphamide, thiotepa and carboplatinCorine Ekhart, Sjoerd Rodenhuis, Paul H M Smits, et al.
Drug Testing and Analysis|February 22, 2023
An Indonesian slimming drug with undeclared ingredients causing harmSonja van de Koppel, Corine Ekhart, Chantal Roelen, et al.
Cancer Chemotherapy and Pharmacology|November 8, 2008
Carboplatin dosing in overweight and obese patients with normal renal function, does weight matter?Corine Ekhart, Sjoerd Rodenhuis, Jan H M Schellens, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|May 9, 2007
Simultaneous quantification of cyclophosphamide and its active metabolite 4-hydroxycyclophosphamide in human plasma by high-performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry (LC-MS/MS)Corine Ekhart, Abadi Gebretensae, Hilde Rosing, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Expert Opinion on Drug Safety|July 18, 2019
Safety profile of non-vitamin K oral anticoagulants (NOACs) from a patient perspective: a web-based cohort event monitoring studyLeàn Rolfes, Corine Ekhart, Judith Hendriks, et al.
Drug Safety|February 28, 2018
Sex Differences in Reported Adverse Drug Reactions of Selective Serotonin Reuptake InhibitorsCorine Ekhart, Florence van Hunsel, Joep Scholl, et al.
Cancer Chemotherapy and Pharmacology|April 24, 2008
Altered cyclophosphamide and thiotepa pharmacokinetics in a patient with moderate renal insufficiencyCorine Ekhart, J Martijn Kerst, Sjoerd Rodenhuis, et al.
Pharmacogenomics|September 1, 2018
Cytochrome P450 genotype and aggressive behavior on selective serotonin reuptake inhibitorsCorine Ekhart, Maja Matic, Agnes Kant, et al.
Pain Practice : the Official Journal of World Institute of Pain|June 28, 2016
Metamizole (Dipyrone) as an Alternative Agent in Postoperative Analgesia in Patients with Contraindications for Nonsteroidal Anti-Inflammatory DrugsJorieke Konijnenbelt-Peters, Charlotte van der Heijden, Corine Ekhart, et al.
Cancer Treatment Reviews|September 6, 2008
An overview of the relations between polymorphisms in drug metabolising enzymes and drug transporters and survival after cancer drug treatmentCorine Ekhart, Sjoerd Rodenhuis, Paul H M Smits, et al.
Pharmacogenetics and Genomics|October 16, 2008
Relations between polymorphisms in drug-metabolising enzymes and toxicity of chemotherapy with cyclophosphamide, thiotepa and carboplatinCorine Ekhart, Sjoerd Rodenhuis, Paul H M Smits, et al.
Drug Testing and Analysis|February 22, 2023
An Indonesian slimming drug with undeclared ingredients causing harmSonja van de Koppel, Corine Ekhart, Chantal Roelen, et al.
Cancer Chemotherapy and Pharmacology|November 8, 2008
Carboplatin dosing in overweight and obese patients with normal renal function, does weight matter?Corine Ekhart, Sjoerd Rodenhuis, Jan H M Schellens, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|May 9, 2007
Simultaneous quantification of cyclophosphamide and its active metabolite 4-hydroxycyclophosphamide in human plasma by high-performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry (LC-MS/MS)Corine Ekhart, Abadi Gebretensae, Hilde Rosing, et al.
Pageof 4